Quantinno Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Quantinno Capital Management's NVO Position: Q1 2026 in Review
Quantinno Capital Management increased its Novo Nordisk (NVO) stake by 10% in Q1 2026, buying an estimated $1.56M and bringing the position to 351,692 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #765.
Quantinno Capital Management first reported a position in NVO in Q2 2022 and has held it in 16 quarters since. The position peaked at $26.4M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Quantinno Capital Management held 351,692 shares of Novo Nordisk worth $12.9M as of Q1 2026.
- Quantinno Capital Management bought 33,006 Novo Nordisk shares in Q1 2026, an estimated $1.56M.
- Novo Nordisk made up 0.02% of Quantinno Capital Management's portfolio in Q1 2026, its #765 holding.
- Quantinno Capital Management first reported a position in Novo Nordisk in Q2 2022 and has held it in 16 quarters since.
- Quantinno Capital Management's Novo Nordisk position peaked at $26.4M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.